Article Details

Millendo Therapeutics (NASDAQ:MLND) Research Coverage Started at Roth Capital

Retrieved on: 2020-02-05 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Millendo Therapeutics (NASDAQ:MLND) Research Coverage Started at Roth Capital. View article details on hiswai:

Excerpt

<div>Finally, <b>Renaissance Technologies</b> LLC raised its holdings in shares of Millendo Therapeutics by 100.3% in the second quarter. <b>Renaissance</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up